Preview

Journal Infectology

Advanced search

Liver cirrhosis as a result of chronic hepatitis C

https://doi.org/10.22625/2072-6732-2014-6-1-67-71

Abstract

The incidence of chronic hepatitis C in St. Petersburg is 124.4 per 100 000 population. The number of patients with liver cirrhosis is significant.


Aim of this study: to examine the demographic, clinical and epidemiological characteristics of patients with cirrhosis in the results of chronic hepatitis C.


Materials and methods: 100 patients with cirrhosis due to chronic hepatitis C in age 31–70 years were included. Patients with infection hepatitis viruses A and B, HIV, alcohol abuse, drug addicts, previously received antiviral therapy were excluded. Liver cirrhosis was diagnosed on the basis clinical, laboratory and instrumental investigations.


Results: most patients (86,2% male and 81,7% female) are socially adapted. In 23,2% of patients antibodies to hepatitis C virus were first detected simultaneously with the diagnosis of cirrhosis. Medical procedures were the most common route of infection (25,6% male and 57,1% female). Genotype 1 was dominant (65.7%). Viral load over 800 000 IU/ml was detected in 36,7% of patients. ALT activity was normal or not more than 2 upper limit of normal in 59% of patients, AST – 47%. Normal levels of total bilirubin were recorded in 37% of cases.


Conclusions: the first detection of antibodies to hepatitis C virus at the stage of cirrhosis, absence of jaundice, normal or low cytolytic activity once again confirms the need for screening for markers of hepatitis C virus. Dominance of genotype 1 is probably due on the one hand with features routes of transmission, and the other – with the speed of transformation chronic hepatitis to cirrhosis.

About the Authors

A. A. Sukhoruk
Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russia
Russian Federation


O. A. Gerasimova
Russian Science Center of Radiology and Surgical Technologies, Saint-Petersburg, Russia
Russian Federation


E. V. Esaulenko
Saint-Petersburg State Pediatric Medical University, Saint-Petersburg, Russia
Russian Federation


References

1. World Health Organization. Viral hepatitis: Report by the Secretariat. [Internet] [cited2014Feb17]. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB126/B126_15-en.pdf

2. World Health Organization. Prevention and control of viral hepatitis infection: Framework for global action. [Internet] [cited2014Feb17]. Available from: http://www. who.int/csr/disease/hepatitis/ GHP_ framework.pdf

3. Shakhgildyan IV, Yasinskiy AA, Mikhaylov MI, et al. Jurnal infektologii. 2010; 2(4): 127-128.

4. Pokrovskiy VI, Zhebrun AB, editors. Viral hepatitis in the Russian Federation: Analytical review. Issue 8. St.Petersburg: Saint-Petersburg Pasteur Scientific and Research Institute of Epidemiology and Microbiology; с 2011. 116р.

5. Mukomolov SL, Levakova IA. Infektsiya i immunitet. 2011; 1(3): 255–262.

6. Feofanova AV. Immunogematologicheskaya otsenka metodov gemokomponentnoy terapii u onkologicheskikh bolnykh [Immunohaematological assessment methods gemokomponentnoy therapy in cancer patients] [master’s thesis]. Saint-Petersburg( Russia): SPbGMU; 2010. Russian.

7. Esaulenko YeV. V mire virusnykh gepatitov. 2013; 4: 14-9.

8. Zhdanov KV, Lobzin Yu V, Gusev DA, et al. Viral hepatitis. Saint-Petersburg (Russia): Foliant; с2011. 304р.


Review

For citations:


Sukhoruk A.A., Gerasimova O.A., Esaulenko E.V. Liver cirrhosis as a result of chronic hepatitis C. Journal Infectology. 2014;6(1):67-71. (In Russ.) https://doi.org/10.22625/2072-6732-2014-6-1-67-71

Views: 1315


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)